Patent application number | Description | Published |
20080249601 | Stent/Graft Assembly - A stent/graft assembly includes a tubular graft connected in substantially end-to-end relationship with a generally tubular stent. Free ends of the stent and graft extend in opposite directions from the end-to-end connection during a pre-deployment orientation of the assembly. However, the graft is inverted during deployment so that free ends of the graft and the stent extend in substantially the same direction from the end-to-end connection in a post-deployment orientation. Thus, at least a portion of the stent is disposed within at least a portion of the graft in a post-deployment orientation of the assembly. | 10-09-2008 |
20100049116 | DIALYSIS CATHETER - A catheter assembly includes catheter having proximal and distal ends and at least one lumen extending between the ends. At least one end of the catheter is formed from a material that can be trimmed to achieve a selected length for the catheter. A tubular connector is telescoped over the catheter and a hub is joined to the tubular connector. Proximal portions of the hub are configured for connection to a medical apparatus. A cuff is mounted around the tubular connector or the catheter. The cuff is formed from a material that will permit or promote the growth of scar tissue for anchoring the catheter device at least on a semi-permanent basis in a patient. | 02-25-2010 |
20100292775 | STENT/GRAFT ASSEMBLY - A stent/graft assembly includes a tubular graft connected in substantially end-to-end relationship with a generally tubular stent. Free ends of the stent and graft extend in opposite directions from the end-to-end connection during a pre-deployment orientation of the assembly. However, the graft is inverted during deployment so that free ends of the graft and the stent extend in substantially the same direction from the end-to-end connection in a post-deployment orientation. Thus, at least a portion of the stent is disposed within at least a portion of the graft in a post-deployment orientation of the assembly. | 11-18-2010 |
20130060319 | STENT/GRAFT ASSEMBLY - A stent/graft assembly includes a tubular graft connected in substantially end-to-end relationship with a generally tubular stent. Free ends of the stent and graft extend in opposite directions from the end-to-end connection during a pre-deployment orientation of the assembly. However, the graft is inverted during deployment so that free ends of the graft and the stent extend in substantially the same direction from the end-to-end connection in a post-deployment orientation. Thus, at least a portion of the stent is disposed within at least a portion of the graft in a post-deployment orientation of the assembly. | 03-07-2013 |
20130297004 | STENT/GRAFT ASSEMBLY - A stent/graft assembly includes a tubular graft connected in substantially end-to-end relationship with a generally tubular stent. Free ends of the stent and graft extend in opposite directions from the end-to-end connection during a pre-deployment orientation of the assembly. However, the graft is inverted during deployment so that free ends of the graft and the stent extend in substantially the same direction from the end-to-end connection in a post-deployment orientation. Thus, at least a portion of the stent is disposed within at least a portion of the graft in a post-deployment orientation of the assembly. | 11-07-2013 |
20150230950 | STENT/GRAFT ASSEMBLY - A stent/graft assembly includes a tubular graft connected in substantially end-to-end relationship with a generally tubular stent. Free ends of the stent and graft extend in opposite directions from the end-to-end connection during a pre-deployment orientation of the assembly. However, the graft is inverted during deployment so that free ends of the graft and the stent extend in substantially the same direction from the end-to-end connection in a post-deployment orientation. Thus, at least a portion of the stent is disposed within at least a portion of the graft in a post-deployment orientation of the assembly. | 08-20-2015 |
Patent application number | Description | Published |
20120237023 | Secure Key Management - A system for implementing computer security is provided. The system includes a computer processor and an application configured to execute on the computer processor, the application implementing a method that includes creating a token and populating a payload section of the token with key material and selecting a wrapping method that specifies how the key material is securely bound to key control information. A structure of the key control information in the token is independent of the wrapping method. Implementing computer security also includes wrapping the key material and binding key control information to the key material in the token. The key control information includes information relating to usage and management of the key material. | 09-20-2012 |
20120275600 | SECURE KEY CREATION - A system for creating a secure key is provided that includes a computer processor and an application configured to execute on the computer processor, the application implementing a method that includes creating a token and populating a key control information section of the token with a value to indicate a minimum number of key parts used to form a key. Creating the secure key also includes populating a payload section of the token with a first key part, binding the key control information section to the payload section, adding a second key part to the first key part and iterating the value and binding the key control information section to the payload section after the second key part has been added. Creating the secure key further includes indicating the key is complete, wherein the key comprises a combination of the first and second key parts. | 11-01-2012 |
20120281836 | SECURE KEY MANAGEMENT - A system for implementing secure key management is provided. The system includes a computer processor and an application configured to execute on the computer processor, the application implementing a method. The method includes populating a section of information associated with a key, the section being populated with information relating to how the key was created. The method also includes populating the section with information relating to how the key was acquired by a secure module; and binding the section to the key, wherein the key is encrypted. | 11-08-2012 |
20120281837 | SECURE KEY MANAGEMENT - A system for secure key management is provided. The system includes a computer processor and an application configured to execute on the computer processor, the application implementing a method. The method includes populating a section of information associated with a key, the section of information being populated with information relating to a level of protection of the key accumulated over time. Secure key management further includes securely binding the section of information to the key, wherein the key is encrypted. | 11-08-2012 |
20120281838 | KEY MANAGEMENT POLICIES FOR CRYPTOGRAPHIC KEYS - A computer program product for secure key management is provided. The computer program product includes a tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for creating a token and populating the token with key material, and binding key control information to the key material. The key control information includes information relating to management of the key material populating one or more key management fields that define attributes that limit distribution of the key material. | 11-08-2012 |
20120281839 | KEY USAGE POLICIES FOR CRYPTOGRAPHIC KEYS - A computer program product for secure key management is provided. The computer program product includes a tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for creating a token and populating the token with key material, and binding key control information to the key material. The key control information includes information relating to usage of the key material populating one or more key usage fields that define attributes that limit actions that may be performed with the key material. | 11-08-2012 |
20130034228 | SECURE KEY CREATION - Creating a secure key includes creating a token and populating a key control information section of the token with a value to indicate a minimum number of key parts used to form a key. Creating the secure key also includes populating a payload section of the token with a first key part, binding the key control information section to the payload section, adding a second key part to the first key part and iterating the value and binding the key control information section to the payload section after the second key part has been added. Creating the secure key further includes indicating the key is complete, wherein the key comprises a combination of the first and second key parts. | 02-07-2013 |
20130039494 | SECURE KEY MANAGEMENT - According to one embodiment, a method for implementing secure key management is provided. The method includes populating a section of information associated with a key, the section being populated with information relating to how the key was created. The method also includes populating the section with information relating to how the key was acquired by a secure module; and binding the section to the key, wherein the key is encrypted. | 02-14-2013 |
20130039495 | SECURE KEY MANAGEMENT - According to one embodiment, a method for implementing computer security is provided. The method includes creating a token and populating a payload section of the token with key material and selecting a wrapping method that specifies how the key material is securely bound to key control information, wherein a structure of the key control information in the token is independent of the wrapping method. The method also includes wrapping the key material and binding key control information to the key material in the token, wherein the key control information includes information relating to usage and management of the key material. | 02-14-2013 |
20130044879 | SECURE KEY MANAGEMENT - Secure key management includes populating a section of information associated with a key, the section of information being populated with information relating to a level of protection of the key accumulated over time. Secure key management further includes securely binding the section of information to the key, wherein the key is encrypted. | 02-21-2013 |
20130044880 | KEY MANAGEMENT POLICIES FOR CRYPTOGRAPHIC KEYS - A computer program product for secure key management is provided. The computer program product includes a tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for performing a method. The method includes creating a token and populating the token with key material, and binding key control information to the key material. The key control information includes information relating to management of the key material populating one or more key management fields that define attributes that limit distribution of the key material. | 02-21-2013 |
20130103954 | KEY USAGE POLICIES FOR CRYPTOGRAPHIC KEYS - A computer program product for secure key management is provided. The computer program product includes a tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for performing a method. The method includes creating a token and populating the token with key material, and binding key control information to the key material. The key control information includes information relating to usage of the key material populating one or more key usage fields that define attributes that limit actions that may be performed with the key material. | 04-25-2013 |
Patent application number | Description | Published |
20110199843 | Strobe Offset in Bidirectional Memory Strobe Configurations - A method and apparatus for determining correct timing for receiving, in a host in a memory system, of a normal toggle transmitted by an addressed memory chip on a bidirectional data strobe. An offset in the data strobe is established, either by commanding the addressed memory chip, in a training period, to drive the data strobe to a known state, except during transmission of a normal toggle, or by providing a voltage offset between a true and a complement phase in the data strobe, or by providing a circuit bias in a differential receiver on the host the receives the data strobe. A series of read commands are transmitted by the host to the addressed memory chip, which responds by transmitting the normal toggle. Timing of reception of the normal toggle as received by the host chip is adjusted until the normal toggle is correctly received. | 08-18-2011 |
20120300564 | Strobe Offset in Bidirectional Memory Strobe Configurations - A method and apparatus for determining correct timing for receiving, in a host in a memory system, of a normal toggle transmitted by an addressed memory chip on a bidirectional data strobe. An offset in the data strobe is established, either by commanding the addressed memory chip, in a training period, to drive the data strobe to a known state, except during transmission of a normal toggle, or by providing a voltage offset between a true and a complement phase in the data strobe, or by providing a circuit bias in a differential receiver on the host the receives the data strobe. A series of read commands are transmitted by the host to the addressed memory chip, which responds by transmitting the normal toggle. Timing of reception of the normal toggle as received by the host chip is adjusted until the normal toggle is correctly received. | 11-29-2012 |
20130265085 | IMPLEMENTING VOLTAGE FEEDBACK GATE PROTECTION FOR CMOS OUTPUT DRIVERS - A method and circuit for implementing protection for complementary metal oxide semiconductor (CMOS) output drivers, and a design structure on which the subject circuit resides are provided. An output driver stage transistor stack includes a plurality of series connected PFETs series connected with a plurality of series connected NFETs connected between upper and lower voltage supply rails. A pair of offset DC voltage levels provides respective gate voltages of an intermediate PFET and an intermediate NFET in the output driver stage transistor stack. A pair of pre-driver circuits receiving voltage level translated logic signals drive respective gate inputs of the upper PFET and the lower NFET in the output driver stage transistor stack. A voltage feedback circuit provides respective gate voltages of the PFET and NFET connected together in the output driver stage transistor stack. | 10-10-2013 |
20130265091 | IMPLEMENTING LOW DUTY CYCLE DISTORTION AND LOW POWER DIFFERENTIAL TO SINGLE ENDED LEVEL SHIFTER - A method and circuit for implementing low duty cycle distortion and low power differential to single ended level shifter, and a design structure on which the subject circuit resides are provided. The circuit includes an input differential amplifier providing positive and negative differential amplifier output signals coupled to an output amplifier providing a single ended output signal. The output amplifier amplifies and inverts the negative differential amplifier output signal. The output amplifier amplifies and superimposes the positive differential amplifier output signal with the amplified and inverted negative differential amplifier output signal, providing the single ended output signal with low duty cycle distortion. | 10-10-2013 |
Patent application number | Description | Published |
20130152288 | CERVICAL SPINE PROTECTION DEVICE - A cervical spine protection device including a lower portion engaged with a user's shoulders, and an upper portion designed for engagement with a user's helmet when an axial force is applied to a portion of the user's helmet, where the upper portion has an opening at the rearward facing side of a user's body. The device further includes a middle portion disposed between the lower portion and the upper portion, and an inside portion shaped to fit around a user's neck. The axial force applied to the top portion of the user's helmet is at least partially absorbed by the cervical spine protection device and at least partially directed away from a cervical spinal column of the user by the cervical spine protection device. The cervical spine protection device allows extension of the head and neck during athletic movement. | 06-20-2013 |
20140109305 | SHOULDER PADS INCORPORATING A CERVICAL SPINE PROTECTION DEVICE - A shoulder pad having a cervical spine protection system including shoulder pads and a cervical spine protection device. The cervical spine protection device includes a lower portion engaged with a user's shoulders, an upper portion designed for engagement with a user's helmet when an axial force is applied to a portion of the helmet, the upper portion having a front section, a rear section, and side sections, where the front section, rear section, and side sections of the upper portion have a top surface. The cervical spine protection device also includes a middle portion disposed between the lower portion and the upper portion. The cervical spine protection device further includes an outside portion shaped to engage with shoulder pads, where the outside portion comprises a substantially c-shaped design, with the lower portion and the upper portion extending laterally further than the middle portion away from the user's neck, and an inside portion shaped to fit around a user's neck. | 04-24-2014 |
Patent application number | Description | Published |
20080245968 | DUAL-SCREEN DIGITAL RADIOGRAPHIC IMAGING DETECTOR ARRAY - A radiographic imaging device has a first scintillating phosphor screen having a first thickness and a second scintillating phosphor screen having a second thickness. A transparent substrate is disposed between the first and second screens. An imaging array formed on a side of the substrate includes multiple photosensors and an array of readout elements. | 10-09-2008 |
20090199401 | METHOD FOR FORMING CAST FLEXIBLE SUBSTRATE AND RESULTANT SUBSTRATE AND ELECTRONIC DEVICE - A method for forming an electronic device provides a casting master having a casting surface, and deposits a substrate material onto the casting surface to form a flexible substrate sheet of predetermined thickness, wherein the flexible substrate sheet has a circuit-side surface that is formed against the casting surface. The flexible substrate sheet is released from the master and secured against a carrier, with the circuit-side surface facing outward. An electronic device is then formed on the circuit-side surface. | 08-13-2009 |
20090200550 | METHOD FOR FORMING AN ELECTRONIC DEVICE ON A FLEXIBLE SUBSTRATE SUPPORTED BY A DETACHABLE CARRIER - A method for forming an electronic device provides a carrier formed from a composite material comprising a plastic binder and an embedded material. A substrate material is attached to the carrier. The substrate is processed to form the electronic device thereon. The substrate is then detached from the carrier to yield the resultant electronic device. | 08-13-2009 |
20090202857 | METHOD FOR FORMING AN ELECTRONIC DEVICE ON A FLEXIBLE METALLIC SUBSTRATE AND RESULTANT DEVICE - A method for forming an electronic device provides a metallic carrier having a retaining surface and secures a contact surface of a metallic substrate material against the retaining surface of the metallic carrier. The substrate is processed to form the electronic device thereon; and the metallic substrate material released from the metallic carrier, to yield the completed electronic device. | 08-13-2009 |
Patent application number | Description | Published |
20100136026 | Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis - The present invention concerns inhibition of SHIP expression and/or function in mammalian subjects to direct HSC from the bone marrow to other sites in the body (such as the spleen and/or liver), where they then re-establish blood cell production. The method of the invention can be employed, for example, to rescue or enhance blood cell recovery during bone marrow impairment due to bone-seeking radioisotope exposure, chemotherapy, radiotherapy, infection, or genetic or congenital defects. Preferably, inhibition of SHIP expression and/or function is achieved by administering an effective amount of one or more SHIP inhibitors to the subject. In one embodiment, the subject is suffering from, or at risk of developing, bone marrow failure (such as an aplastic bone marrow failure syndrome). In another embodiment, the subject is suffering from, or at risk of, exposure to a bone-seeking radioisotope. In another embodiment, the subject is suffering from, or at risk of developing, fibrotic or damaged bone marrow due to chemotherapy and/or radiation therapy for cancer. | 06-03-2010 |
20100144841 | CONTROL OF NK CELL FUNCTION AND SURVIVAL BY MODULATION OF SHIP ACTIVITY - Inhibition of dendritic cell function in solid organ grafts or allogeneic bone marrow transplants prior to or during engraftment by blocking SH2-containing inositol phosphatase (SHIP) expression or function is taught as a method of abrogating immune rejection and thereby increasing the efficacy of engraftment of an allogeneic bone marrow transplant or solid organ allograft or xenograft. Also disclosed is a transgenic mouse having the genotype SHIP | 06-10-2010 |
20100183521 | METHODS OF DETECTING AND TREATING COLON DISORDERS - The subject invention pertains to a method of detecting colon disorders including inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, based on underexpression of Lipopolysaccharide Responsive Beige-like Anchor (LRBA). Advantageously, the invention may be used to test for inflammatory bowel disease using a blood sample from a subject before a more invasive test for colon disorders is employed. The invention also pertains to methods of treating a colon disorder in a subject in which the colon disorder is detected. | 07-22-2010 |
20100260730 | SHIP-Deficiency to Increase Megakaryocyte Progenitor Production - The invention concerns a method for increasing megakaryocyte and megakaryocyte progenitor numbers in vitro or in vivo by suppressing SH2-containing inositol-5-phosphatase (SHIP) function in megakaryocytes or megakaryocyte progenitors expressing the SHIP gene. SHIP function can be suppressed by administering an interfering RNA, or other SHIP inhibitor, to the megakaryocytes or megakaryocyte progenitors in vitro or in vivo. | 10-14-2010 |
20100266548 | LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof - The present invention relates to a novel LPS-responsive and Beige-like Anchor gene (lrba), variants of the lrba gene, fragments of the lrba gene, and polypeptides encoded thereby. The subject invention also pertains to lrba interfering RNA, and uses thereof. In another aspect, the present invention also includes methods of inhibiting tumor growth in a patient by suppressing lrba function. | 10-21-2010 |
20110052546 | Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation - The instant invention teaches the inhibition of SHIP expression, or function for the increased efficacy of autologous stem cell transplants. In another embodiment, interference with SHIP function can be used to temporarily expand and mobilize the hematopoietic stem cell compartment to assist with leukapheresis, to promote hematopoietic recovery after myeloablation treatments, to deplete target stem cell clones (such as leukemic clones and other tumor stem cell types), and to deplete, or damage, the repopulating ability of the endogenous hematopoietic stem cell pool in order to allow transplanted hematopoietic stem cells to better home and engraft and to promote in vivo expansion and mobilization of other organ-specific stem cell populations (e.g., mesenchymal, mammary). | 03-03-2011 |
20110064704 | SHIP-DEFICIENCY TO INCREASE MEGAKARYOCYTE AND PLATELET PRODUCTION - A method of increasing megakaryocytes and platelet numbers in a patient comprising the step of inhibiting SHIP expression, including SHIP's enzymatic activity and signaling functions, whereby normal blood clotting is induced. | 03-17-2011 |
20120178725 | METHOD OF MODULATING SHIP ACTIVITY - A method of treating or preventing an immune disorder, such as graft versus host disease, in a subject. The method includes the administering a SHIP1 inhibitor, such as 3α-aminocholestane, to a subject in need of treatment. Thus, SHIP1 inhibitors taught herein represent a novel class of small molecules that have the potential to enhance allogeneic transplantation, boost innate immunity and improve the treatment of hematologic malignancies. | 07-12-2012 |
20130102577 | SHIP INHIBITORS AND USES THEREOF - The present invention relates to SHIP inhibitor compounds and methods for using these compounds. In particular, the present invention discloses the following methods: (i) a method of treating graft versus host disease in a subject; (ii) a method of inhibiting a SHIP1 protein in a cell; (iii) a method of selectively inhibiting a SHIP1 protein in a cell; (iv) a method for treating or preventing graft-versus-host disease (GVHD) in a recipient of an organ or tissue transplant; (v) a method of modulating SHIP activity in a cell expressing SHIP1 or SHIP2; (vi) a method of ex vivo or in vitro treatment of transplants; (vii) a method of inhibiting tumor growth and metastasis in a subject; (viii) a method of treating a hematologic malignancy in a subject; (ix) a method of inducing apoptosis of multiple myeloma cells; (x) a method of treating multiple myeloma in a subject; (xi) a method of inhibiting the proliferation of a human breast cancer cell; and (xii) a method of treating breast cancer in a subject. | 04-25-2013 |
20140287943 | ASSAY FOR SHIP1 EXPRESSION, ACTIVITY AND SEQUENCE ALTERATIONS AS A PREDICTOR OF INFLAMMATORY BOWEL DISEASE RISK - The present disclosure is directed to detecting colon disorders by measuring the expression of SHIP1 in a sample of PBMCs. One method includes the following steps, obtaining a sample including peripheral blood mononuclear cells (PBMCs) from a subject and determining whether SHIP1 is underexpressed in the PBMCs or lacks normal enzymatic activity. The present disclosure is also directed to a method of determining the expression of SHIP1 protein expression and SHIP1 enzyme activity in PBMCs. This method includes the following steps, obtaining a sample comprising PBMCs from a subject and determining the amount of SHIP1 in the PBMCs. | 09-25-2014 |